Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
MGE Energy Inc
MGEE
$3.09B
| $1.63M | ﹤0.01% |
22,338
+16,083
| +257% | +$1.11M |
|
|
VRNT
4677
CALL
DELISTED
Verint Systems
VRNT
| $1.63M | ﹤0.01% |
59,479
+1,178
| +2% | +$35.4K |
|
|
BTEC
4678
DELISTED
Principal Exchange-Traded Funds Principal Healthcare Innovators ETF
BTEC
| $1.63M | ﹤0.01% |
47,946
+31,780
| +197% | +$1.05M |
|
|
FLXN
4679
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.63M | ﹤0.01% |
132,558
-178,352
| -57% | -$2.06M |
|
|
DOVA
4680
PUT
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $1.63M | ﹤0.01% |
+115,500
| New | +$1.1M |
|
|
FMBI
4681
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $1.63M | ﹤0.01% |
79,511
+56,342
| +243% | +$1.17M |
|
4682
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.72B
| $1.63M | ﹤0.01% |
35,602
-4,705
| -12% | -$212K |
|
|
MXIM
4683
PUT
DELISTED
Maxim Integrated Products
MXIM
| $1.63M | ﹤0.01% |
27,200
+13,300
| +96% | +$758K |
|
4684
RLI Corp
RLI
$5.85B
| $1.63M | ﹤0.01% |
+37,940
| New | +$1.56M |
|
|
AIMT
4685
PUT
DELISTED
Aimmune Therapeutics
AIMT
| $1.63M | ﹤0.01% |
78,100
+39,400
| +102% | +$811K |
|
4686
PUT
Barclays
BCS
$94.7B
| $1.63M | ﹤0.01% |
218,106
+34,717
| +19% | +$274K |
|
|
DESP
4687
DELISTED
Despegar.com
DESP
| $1.63M | ﹤0.01% |
116,994
-19,779
| -14% | -$270K |
|
|
JKS
4688
JinkoSolar
JKS
$877M
| $1.63M | ﹤0.01% |
74,925
+54,096
| +260% | +$1.09M |
|
4689
Veracyte
VCYT
$3.32B
| $1.63M | ﹤0.01% |
56,993
-152,776
| -73% | -$3.82M |
|
4690
W&T Offshore
WTI
$554M
| $1.63M | ﹤0.01% |
327,758
-724,054
| -69% | -$3.9M |
|
4691
Flowers Foods
FLO
$1.59B
| $1.62M | ﹤0.01% |
69,798
+46,222
| +196% | +$1.02M |
|
|
PACW
4692
CALL
DELISTED
PacWest Bancorp
PACW
| $1.62M | ﹤0.01% |
41,800
+9,800
| +31% | +$379K |
|
4693
CALL
Core Laboratories
CLB
$571M
| $1.62M | ﹤0.01% |
31,000
-20,900
| -40% | -$1.23M |
|
4694
Central Pacific Financial
CPF
$996M
| $1.62M | ﹤0.01% |
54,015
+33,537
| +164% | +$978K |
|
4695
iShares Global Consumer Discretionary ETF
RXI
$274M
| $1.62M | ﹤0.01% |
13,662
+6,151
| +82% | +$718K |
|
|
ANSS
4696
PUT
DELISTED
Ansys
ANSS
| $1.62M | ﹤0.01% |
7,900
-26,600
| -77% | -$5.07M |
|
4697
CALL
iShares US Regional Banks ETF
IAT
$693M
| $1.62M | ﹤0.01% |
35,200
+22,200
| +171% | +$1.01M |
|
|
PRAH
4698
PUT
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.62M | ﹤0.01% |
16,300
-7,700
| -32% | -$735K |
|
|
PEGI
4699
PUT
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $1.62M | ﹤0.01% |
70,000
-24,200
| -26% | -$542K |
|
4700
Vanguard Total World Bond ETF
BNDW
$1.89B
| $1.61M | ﹤0.01% |
20,487
+1,052
| +5% | +$81.2K |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.